Clinica Chimica Acta 1999: Vol 286 Index

5 Pages·1999·0.66 MB·English

SS
ELSEaV I4 ER
Clinica Chimica Acta 286 (1999) 275-276
Author index
Volume 286 (1999)
Ailhaud, G., Cell surface receptors, nuclear re- Fagot-Campagna, A., Burrows, N.R., Williamson,
ceptors and ligands that regulate adipose tissue D.F., The public health epidemiology of type 2
development 286, 181 diabetes in children and adolescents: a case
Assmann, G., see Cullen, P. 286, 31 study of American Indian adolescents in the
Southwestern United States 286, 81
Francis, G.A., Perry, R.J., Targeting HDL-mediated
Bernier, L., see Davignon, J. 286, 115
cellular cholesterol efflux for the treatment and
Burnett, J.R., Wilcox, LJ., Huff, MW., Acyl
prevention of atherosclerosis 286, 219
coenzyme A: cholesterol acyltransferase inhibi-
Frohlich, J.J., see DobidSova, M. 286, 257
tion and hepatic apolipoprotein B_ secretion
286, 231 Fruchart, J.C., see Duriez, P. 286, 97
Burrows, N.R.,, see Fagot-Campagna, A. 286, 81
Hajjar, D.P., see Nicholson, A.C. 286, 23
Hajra, L., see Cybulsky, M.1. 286, 207
Cianflone, K., see Saleh, J. 286, 163 Hegele, R.A., Genetic prediction of atherosclerosis:
Cianflone, K., see Sniderman, A.D. 286, 7 lessons from studies in native Canadian popula-
Cohn, J.S., see Davignon, J. 286, 115 tions 286, 47
Cole, D.E.C., see Langman, LJ. 286, 63 Huff, M.W., see Burnett, J.R. 286, 231
Connelly, PW., The role of hepatic lipase in
lipoprotein metabolism 286, 243 liyama, K., see Cybulsky, M.I. 286, 207
Cullen, P., Assmann, G., High risk strategies for
atherosclerosis 286, 31 Lamarche, B., Rashid, S., Lewis, G.F., HDL metab-
Cybulsky, M.I., Lichtman, A.H., Hajra, L., liyama, olism in hypertriglyceridemic states: an over-
K., Leukocyte adhesion molecules in view 286, 145
atherogenesis 286, 207 Langman, LJ., Cole, D.E.C., Homocysteine:
cholesterol of the 90s? 286, 63
Davignon, J., Cohn, J.S., Mabile, L., Bernier, L., Lewis, G.F., see Lamarche, B. 286, 145
Apolipoprotein E and atherosclerosis: insight Lichtman, A.H., see Cybulsky, M.I. 286, 207
from animal and human studies 286, 115
Dhaliwal, B.S., Steinbrecher, U.P., Scavenger re-
Mabile, L., see Davignon, J. 286, 115
ceptors and oxidized low density lipoproteins
286, 191
Nicholson, A.C., Hajjar, D.P., Herpesviruses and
DobiaSova, M., Frohlich, J.J., Advances in under-
thrombosis: Activation of coagulation on the
standing of the role of lecithin cholesterol
endothelium 286, 23
acyltransferase (LCAT) in cholesterol transport
286, 257
Perry, R.J., see Francis, G.A. 286, 219
Duriez, P., Fruchart, J.C., High-density lipoprotein
subclasses and apolipoprotein A-I 286, 97
Rashid, S., see Lamarche, B. 286, 145
PII: S009-8981(99)00147-3
276 Author index vol. 286 (1999)
Saleh, J., Sniderman, A.D., Cianflone, K., Regula- Steinbrecher, U.P., see Dhaliwal, B.S. 286, 191
tion of plasma fatty acid metabolism 286, 163
Sniderman, A.D., Cianflone, K., Lipids and vascu- Wilcox, LJ., see Burnett, J.R. 286, 231
lar disease: what we do and do not know 286, Williamson, D.F., see Fagot-Campagna, A. 286,
>
81
Sniderman, A.D., see Saleh, J. 286, 163
SEVIER Clinica Chimica Acta 286 (1999) 277-279
Subject index
Volume 286 (1999)
ACAT inhibitor; ACAT1; ACAT2; Apolipopro- Apolipoprotein E; Atherosclerosis; Gene polymor-
tein B metabolism; Kinetics 286, 231 phism; Lipoproteins; Dyslipidemia; Animal
models 286, 115
ACATI1,; ACAT2; ACAT inhibitor; Apolipoprotein
B metabolism; Kinetics 286, 231 Atherogenesis; Homocysteine; Cardiovascular dis-
ease 286, 63
ACAT2; ACAT1; ACAT inhibitor; Apolipoprotein
B metabolism; Kinetics 286, 231 Atherosclerosis; Apolipoprotein E; Gene polymor-
phism; Lipoproteins; Dyslipidemia; Animal
Adipose tissue development; Cell surface recep- models 286, 115
tors; Nuclear receptors; Ligands 286, 181
Atherosclerosis; Diabetes; Obesity; Polygenic dis-
Adolescents; Epidemiology; Public health; Type 2 ease 286, 47
diabetes; Children; Obesity 286, 81
Atherosclerosis; High density lipoprotein; HDL;
Animal models; Atherosclerosis; Apolipoprotein Cholesterol; Cholesterol efflux; Cardioprotection
E; Gene polymorphism; Lipoproteins; 286, 219
Dyslipidemia 286, 115
Atherosclerosis; LCAT; Structure and function;
Apo A-I; HDL; Apo A-II; Apo A-IV; Transgenesis; LCAT deficiency; FER,,,,,; Reverse cholesterol
Mice; Rabbit; Clinical studies 286, 97 transport 286, 257
Apo A-II; HDL; Apo A-I; Apo A-IV; Trans- Atherosclerosis; Leukocytes; VCAM-1; ICAM-1;
genesis; Mice; Rabbit; Clinical studies 286, 97 Mouse models 286, 207
Apo A-IV; HDL; Apo A-I; Apo A-Il; Transgenesis; Atherosclerosis; Macrophages; Scavenger recep-
Mice; Rabbit; Clinical studies 286, 97 tors; Oxidized LDL; Endothelial cells 286, 191
Apolipoprotein A-I; Kinetic studies; HDL choles- Cardioprotection; High density lipoprotein; HDL;
terol; Triglycerides; Cholesteryl ester transfer Cholesterol; Cholesterol efflux; Atherosclerosis
protein; Intravascular lipases 286, 145 286, 219
Apolipoprotein B; Coronary disease; Prevention; Cardiovascular disease; Homocysteine;
Risk factors for vascular disease 286, 7 Atherogenesis 286, 63
Apolipoprotein B metabolism; ACAT1; ACAT2; Cell surface receptors; Nuclear receptors; Lig-
ACAT inhibitor; Kinetics 286, 231 ands; Adipose tissue development 286, 181
PII: S009-8981(99)00148-5
278 Subject index vol. 286 (1999)
Children; Epidemiology; Public health; Type 2 Cholesterol efflux; Atherosclerosis; Cardiop-
diabetes; Adolescents; Obesity 286, 81 rotection 286, 219
Cholesterol; High density lipoprotein; HDL; HDL cholesterol; Apolipoprotein A-I; Kinetic
Cholesterol efflux; Atherosclerosis; Cardiop- studies; Triglycerides; Cholesteryl ester transfer
rotection 286, 219 protein; Intravascular lipases 286, 145
Cholesterol efflux; High density lipoprotein; HDL; Heparin; Hepatic lipase; Lipoproteins; Lipoprotein
Cholesterol; Atherosclerosis; Cardioprotection lipase; Triglyceride; Phospholipid; L »oprotein
286, 219
receptors 286, 243
Cholesteryl ester transfer protein; Apolipoprotein
Hepatic lipase; Lipoproteins; Lipoprotein lipase;
A-I; Kinetic studies; HDL cholesterol; Tri-
Triglyceride; Phospholipid; Heparin; Lipoprotein
glycerides; Intravascular lipases 286, 145
receptors 286, 243
Clinical studies; HDL; Apo A-I; Apo A-II; Apo
A-IV; Transgenesis; Mice; Rabbit 286, 97 Herpesviruses; Thrombosis; Coagulation; Endo-
thelium; Vascular smooth muscle cell 286, 23
Coagulation; Herpesviruses; Thrombosis; Endo-
High density lipoprotein; HDL; Cholesterol;
thelium; Vascular smooth muscle cell 286, 23
Cholesterol efflux; Atherosclerosis; Cardio-
protection 286, 219
Coronary disease; Prevention; Apolipoprotein B;
Risk factors for vascular disease 286, 7
Homocysteine; Atherogenesis; Cardiovascular dis-
Coronary heart disease; Risk factors; Risk assess- ease 286, 63
ment 286, 31
ICAM-1; Leukocytes; Atherosclerosis, VCAM-1;
Diabetes; Atherosclerosis; Obesity; Polygenic dis- Mouse models 286, 207
ease 286, 47
Intravascular lipases; Apolipoprotein A-I; Kinetic
Dyslipidemia; Atherosclerosis; Apolipoprotein E; studies; HDL cholesterol; Triglycerides; Choles-
Gene polymorphism; Lipoproteins; Animal teryl ester transfer protein 286, 145
models 286, 115
Kinetic studies; Apolipoprotein A-I; HDL choles-
Endothelial cells; Macrophages; Scavenger recep- terol; Triglycerides; Cholesteryl ester transfer
tors; Oxidized LDL; Atherosclerosis 286, 191 protein; Intravascular lipases 286, 145
Endothelium; Herpesviruses; Thrombosis; Coagu- Kinetics; ACAT1; ACAT2; ACAT inhibitor;
lation; Vascular smooth muscle cell 286, 23 Apolipoprotein B metabolism 286, 231
Epidemiology; Public health; Type 2 diabetes; LCAT,; Structure and function; LCAT deficiency;
Children; Adolescents; Obesity 286, 81 FER,,,,; Reverse cholesterol transport; Athero-
sclerosis 286, 257
FER,,,; LCAT; Structure and function; LCAT
deficiency; Reverse cholesterol _ transport; LCAT deficiency; LCAT; Structure and function;
Atherosclerosis 286, 257 FER,,,,; Reverse cholesterol transport; Athero-
sclerosis 286, 257
Gene polymorphism; Atherosclerosis; Apolipopro-
tein E; Lipoproteins; Dyslipidemia; Animal Leukocytes; Atherosclerosis; VCAM-1; ICAM-1;
models 286, 115 Mouse models 286, 207
HDL; Apo A-I; Apo A-II; Apo A-IV; Transgenesis; Ligands; Cell surface receptors; Nuclear receptors;
Mice; Rabbit; Clinical studies 286, 97 Adipose tissue development 286, 181
HDL; High density lipoprotein; Cholesterol; Lipoprotein lipase; Hepatic lipase; Lipoproteins;
Subject index vol. 286 (1999) 279
Triglyceride; Phospholipid; Heparin; Lipoprotein Rabbit; HDL; Apo A-I; Apo A-II; Apo A-IV;
receptors 286, 243 Transgenesis; Mice; Clinical studies 286, 97
Lipoprotein receptors, Hepatic lipase; Lipopro- Reverse cholesterol transport; LCAT; Structure
teins; Lipoprotein lipase; Triglyceride; Phos- and function; LCAT deficiency; FER HDL?
pholipid; Heparin 286, 243 Atherosclerosis 286, 257
Lipoproteins; Atherosclerosis; Apolipoprotein E; Risk assessment; Coronary heart disease; Risk
Gene polymorphism; Dyslipidemia; Animal factors 286, 31
models 286, 115
Risk factors; Coronary heart disease; Risk assess-
Lipoproteins; Hepatic lipase; Lipoprotein lipase; ment 286, 31
Triglyceride; Phospholipid; Heparin; Lipoprotein
receptors 286, 243 Risk factors for vascular disease; Coronary dis-
ease; Prevention; Apolipoprotein B 286, 7
Macrophages; Scavenger receptors; Oxidized
LDL; Atherosclerosis; Endothelial cells 286, Scavenger receptors; Macrophages; Oxidized
191 LDL; Atherosclerosis; Endothelial cells 286,
19]
Mice; HDL; Apo A-I; Apo A-II; Apo A-IV,
Transgenesis; Rabbit; Clinical studies 286, 97 Structure and function; LCAT; LCAT deficiency;
FER,,»,; Reverse cholesterol transport; Athero-
Mouse models; Leukocytes; Atherosclerosis; sclerosis 286, 257
VCAM-1; ICAM-1 286, 207
Thrombosis; Herpesviruses; Coagulation; Endo-
Nuclear receptors; Cell surface receptors; Lig- thelium; Vascular smooth muscle cell 286, 23
ands; Adipose tissue development 286, 181
Transgenesis; HDL; Apo A-I; Apo A-II; Apo A-
Obesity; Atherosclerosis; Diabetes; Polygenic dis- IV; Mice; Rabbit; Clinical studies 286, 97
ease 286, 47
Triglyceride; Hepatic lipase; _ Lipoproteins;
Obesity; Epidemiology; Public health; Type 2 Lipoprotein lipase; Phospholipid; Heparin;
diabetes; Children; Adolescents 286, 81 Lipoprotein receptors 286, 243
Oxidized LDL; Macrophages; Scavenger recep- Triglycerides; Apolipoprotein A-I; Kinetic studies;
tors; Atherosclerosis; Endothelial cells 286, 191 HDL cholesterol; Cholesteryl ester transfer pro-
tein; Intravascular lipases 286, 145
Phospholipid; Hepatic lipase; _L ipoproteins;
Lipoprotein lipase; Triglyceride; Heparin; Type 2 diabetes; Epidemiology; Public health;
Lipoprotein receptors 286, 243 Children; Adolescents; Obesity 286, 81
Polygenic disease; Atherosclerosis; Diabetes; Ob- Vascular smooth muscle cell; Herpesviruses;
esity 286, 47 Thrombosis; Coagulation; Endothelium 286, 23
Prevention; Coronary disease; Apolipoprotein B; VCAM-1; Leukocytes; Atherosclerosis; ICAM-1;
Risk factors for vascular disease 286, 7 Mouse models 286, 207
Public health; Epidemiology; Type 2 diabetes;
Children; Adolescents; Obesity 286, 81